Sirona Biochem Corp
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, engages in the development and sale of cosmetic and pharmaceutical active ingredients in Canada and France. The company's programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, anti-wrinkle compound, and anti-viral program. The company … Read more
Sirona Biochem Corp (SRBCF) - Total Assets
Latest total assets as of July 2024: $809.18K USD
Based on the latest financial reports, Sirona Biochem Corp (SRBCF) holds total assets worth $809.18K USD as of July 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Sirona Biochem Corp - Total Assets Trend (2006–2023)
This chart illustrates how Sirona Biochem Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Sirona Biochem Corp - Asset Composition Analysis
Current Asset Composition (October 2023)
Sirona Biochem Corp's total assets of $809.18K consist of 99.1% current assets and 0.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 55.4% |
| Accounts Receivable | $444.44K | 43.1% |
| Inventory | $-438.56K | -42.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2006–2023)
This chart illustrates how Sirona Biochem Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sirona Biochem Corp's current assets represent 99.1% of total assets in 2023, a decrease from 100.0% in 2006.
- Cash Position: Cash and equivalents constituted 55.4% of total assets in 2023, down from 100.0% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2006.
- Asset Diversification: The largest asset category is accounts receivable at 43.1% of total assets.
Sirona Biochem Corp Competitors by Total Assets
Key competitors of Sirona Biochem Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Sirona Biochem Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Sirona Biochem Corp generates 0.03x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Sirona Biochem Corp is currently not profitable relative to its asset base.
Sirona Biochem Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.34 | 1.50 | 4.63 |
| Quick Ratio | 0.66 | 1.46 | 5.05 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-1.57 Million | $ 361.97K | $ 3.34 Million |
Sirona Biochem Corp - Advanced Valuation Insights
This section examines the relationship between Sirona Biochem Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 36.93 |
| Latest Market Cap to Assets Ratio | 1.58 |
| Asset Growth Rate (YoY) | -20.0% |
| Total Assets | $1.03 Million |
| Market Capitalization | $1.63 Million USD |
Valuation Analysis
Above Book Valuation: The market values Sirona Biochem Corp's assets above their book value (1.58 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Sirona Biochem Corp's assets decreased by 20.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Sirona Biochem Corp (2006–2023)
The table below shows the annual total assets of Sirona Biochem Corp from 2006 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-10-31 | $1.03 Million | -20.04% |
| 2022-10-31 | $1.29 Million | +0.25% |
| 2021-10-31 | $1.29 Million | -39.76% |
| 2020-10-31 | $2.14 Million | -49.79% |
| 2019-10-31 | $4.26 Million | +452.48% |
| 2018-10-31 | $770.51K | -38.41% |
| 2017-10-31 | $1.25 Million | -59.97% |
| 2016-10-31 | $3.13 Million | -34.16% |
| 2015-10-31 | $4.75 Million | +38.45% |
| 2014-10-31 | $3.43 Million | -1.70% |
| 2013-10-31 | $3.49 Million | +30.30% |
| 2012-10-31 | $2.68 Million | -22.02% |
| 2011-10-31 | $3.43 Million | +256.33% |
| 2010-10-31 | $963.25K | +81.41% |
| 2009-10-31 | $530.98K | -50.90% |
| 2008-10-31 | $1.08 Million | -8.58% |
| 2007-10-31 | $1.18 Million | +1083.00% |
| 2006-10-31 | $100.00K | -- |